antibodi
use
number
therapeut
procedur
targetspecif
anticanc
therapi
immunosuppress
purg
prior
bone
marrow
transplant
antibodi
nonhuman
origin
administr
often
result
gener
advers
immun
respons
also
limit
efficaci
human
usual
perform
lessen
occurr
respons
improv
circul
halflif
restor
effector
function
current
human
strategi
includ
retent
variabl
domain
specificitydetermin
residu
sdr
graft
complementaritydetermin
region
cdr
veneer
human
howev
may
decreas
thermal
stabil
antibodi
result
affin
reduct
well
amyloid
fibril
format
especi
substitut
leav
human
antibodi
prone
unfold
studi
indic
potenti
form
fibril
gener
properti
polypeptid
chain
propens
amyloidosi
larg
influenc
sequenc
stabil
nativ
state
furthermor
evid
antibodi
sequenc
notabl
kappa
light
chain
sequenc
becom
prone
fibril
format
due
point
mutat
acquir
affin
matur
apart
event
lead
misfold
conform
transit
alpha
helic
beta
sheet
partial
complet
unfold
could
lead
amyloidosi
consequ
would
interest
develop
method
predict
event
well
identifi
mutat
could
lead
amyloidosi
current
number
comput
method
avail
amyloidogen
potenti
predict
gener
use
either
physicochem
properti
amino
acid
creat
model
predict
aggreg
rate
mutat
identifi
hotspot
inform
overlap
amyloidogen
polypeptid
decomposit
recent
method
use
mean
pack
densiti
profil
also
report
found
abl
predict
amyloidogen
intrins
disord
region
peptid
protein
nevertheless
method
yield
predict
region
sequenc
potenti
amyloidogen
highli
similar
sequenc
case
amyloidogen
nonamyloidogen
antibodi
result
method
easi
distinguish
see
supplementari
inform
addit
file
paper
explor
use
naiv
bayesian
decis
tree
classif
method
predict
amyloidogen
propens
antibodi
sequenc
primari
applic
predict
amyloidogen
propens
engin
antibodi
mind
naiv
bayesian
method
provid
advantag
take
effect
mutat
specif
combin
posit
account
decis
tree
hand
intuit
allow
evalu
factor
may
contribut
amyloidogen
potenti
gener
classifi
method
amyloidogen
antibodi
sequenc
deriv
twelv
differ
germlin
correspond
nonamyloidogen
deriv
use
unambigu
assign
amyloidogen
nonamyloidogen
sequenc
respect
germlin
critic
premis
paper
germlin
dna
element
defin
basic
inherit
antibodi
repertoir
individu
rearrang
mutat
respons
foreign
antigen
indic
previous
sequenc
becom
prone
fibril
format
mutat
process
consequ
gener
separ
align
amyloidogen
nonamyloidogen
deriv
singl
germlin
might
lead
identif
mutat
pattern
characterist
exclus
associ
amyloidosi
critic
sequenc
assign
correctli
germlin
order
ensur
mutat
observ
actual
mutat
aris
incorrect
align
align
use
paper
handannot
test
classifi
evalu
effect
train
set
size
holdout
test
set
consist
addit
amyloidogen
sequenc
nonamyloidogen
sequenc
eight
twelv
germlin
use
naiv
bayesian
method
sole
base
posit
inform
yield
predict
accuraci
amyloidform
loo
crossvalid
consist
accuraci
holdout
test
set
latter
includ
train
set
loo
crossvalid
accuraci
increas
sequenc
classifi
use
decis
tree
hand
yield
averag
predict
accuraci
holdout
test
set
loo
crossvalid
perform
evalu
accuraci
bayesian
classifi
particular
method
use
allow
calibr
data
reus
test
sampl
simul
predict
futur
unknown
averag
accuraci
valid
classifi
amyloidogen
sequenc
nonamyloidogen
sequenc
misclassifi
tabl
amc
namc
valid
perform
holdout
test
set
yield
averag
accuraci
fall
within
loo
cross
valid
result
tabl
test
evalu
effect
train
set
size
holdout
test
set
combin
origin
train
set
gener
new
set
classifi
subject
loo
crossvalid
yield
higher
averag
accuraci
tabl
amc
new
order
construct
decis
tree
analyz
natur
mutat
exclus
associ
amyloid
former
use
algorithm
accompani
visual
program
previous
develop
result
indic
mutat
occur
exclus
cdr
residu
fr
residu
amyloidogen
deriv
like
biggest
contributor
misfold
mutat
expos
cdr
result
gener
increas
sheetform
propens
oppos
buri
fr
figur
tabl
contrast
complement
expos
cdr
buri
fr
result
decreas
sheetform
propens
use
inform
branch
weight
initi
decis
tree
tabl
establish
weight
threshold
classif
howev
check
path
taken
amyloidogen
nonamyloidogen
deriv
gener
interestingli
found
consensu
path
either
amyloidogen
nonamyloidogen
sequenc
instead
consensu
path
appear
exist
germlin
figur
tabl
consequ
construct
second
decis
tree
take
germlin
origin
account
case
bayesian
analysi
depend
germlin
weight
along
select
path
either
boost
decreas
figur
tabl
threshold
separ
chosen
maxim
distinguish
sampl
train
set
tabl
evalu
use
holdout
test
set
tabl
list
classif
result
per
germlin
divers
antibodi
repertoir
gener
combinatori
recombin
small
pool
germlin
gene
somat
hypermut
nevertheless
diversif
process
setback
includ
gener
autoreact
antibodi
well
structur
compromis
antibodi
latter
implic
diseas
rang
benign
highlevel
solubl
lightchain
product
patholog
deposit
glomerular
basal
membran
cell
bone
marrow
plasma
cell
interstiti
tissu
arteri
wall
basement
membran
unwant
effect
often
result
set
mutat
whose
consequ
structur
evid
much
result
unstabl
light
chain
evad
elimin
posttransl
qualiti
control
avoid
mutat
combin
thereof
critic
antibodi
engin
studi
carri
amyloidogen
antibodi
pattern
link
amyloidosi
found
poshusta
cowork
instanc
report
nonconserv
mutat
account
total
mutat
sequenc
account
mutat
sequenc
also
report
differ
locat
mutat
patient
differ
secret
level
light
chain
specif
impli
posit
mutat
amount
secret
play
import
role
light
chain
amyloidogen
propens
base
studi
patient
low
light
chain
level
advanc
amyloid
deposit
consequ
clear
two
factor
minimum
consid
gener
protocol
predict
amyloid
format
combin
posit
mutat
occur
well
affect
structur
stabil
antibodi
review
caflisch
classifi
comput
approach
use
predict
protein
peptid
aggreg
propens
two
gener
group
first
make
use
physicochem
properti
amino
acid
creat
phenomonolog
model
predict
aggreg
behavior
mutat
second
hand
use
decomposit
amyloidogen
peptid
overlap
segment
simul
level
atom
obtain
estim
aggreg
propens
well
structur
detail
aggreg
program
sinc
develop
deal
amyloidosi
includ
pasta
server
fibril
predict
program
aggrescan
zyggreg
pafig
among
other
nevertheless
algorithm
deal
predict
segment
involv
possibl
involv
amyloidosi
gener
direct
predict
whether
given
sequenc
amyloidogen
propos
method
may
use
complement
exist
predict
protocol
obtain
direct
predict
amyloidogen
antibodi
sequenc
method
may
extend
protein
type
provid
suffici
relat
posit
neg
train
set
naiv
bayesian
classifi
use
probabl
link
hypothes
event
defin
set
attribut
mitchel
naiv
bayesian
classifi
vnb
defin
vj
one
set
v
class
ai
one
n
attribut
describ
event
approach
attract
current
problem
two
possibl
outcom
straightforward
way
appli
use
inform
combin
posit
mutat
occur
amyloidogen
nonamyloidogen
deriv
singl
germlin
exampl
gaug
probabl
test
sequenc
x
deriv
germlin
g
amyloidogen
one
would
use
bay
equat
evalu
associ
posit
combin
mutat
c
x
two
hypothes
xmn
defin
c
pam
pnam
defin
posit
mutat
probabl
amyloidogen
nonamyloidogen
deriv
respect
appli
method
method
section
equat
figur
yield
averag
predict
accuraci
independ
test
set
accuraci
tabl
test
set
use
train
well
accuraci
amyloid
sequenc
classif
increas
significantli
misclassif
nonamyloidogen
sequenc
also
reduc
averag
tabl
nam
test
correl
size
train
set
predict
accuraci
previous
observ
may
noteworthi
mention
predict
accuraci
deriv
germlin
improv
significantli
even
augment
data
set
predict
germlin
similarli
low
decis
tree
interestingli
deriv
implic
light
chain
deposit
diseas
lcdd
interest
featur
lcddassoci
sequenc
synthes
vitro
result
protein
aggreg
furthermor
analysi
sequenc
frequent
show
obviou
predisposit
toward
misfold
may
possibl
explan
difficulti
obtain
correct
predict
amyloidform
deriv
set
treat
outlier
averag
predict
accuraci
gener
howev
imper
increas
train
set
size
term
number
deriv
per
germlin
term
number
germlin
cover
order
improv
perform
classifi
develop
program
automat
gener
train
set
nontrivi
task
howev
beyond
scope
studi
could
also
possibl
consid
characterist
physicochem
structur
effect
mutat
factor
defin
pam
pnam
nevertheless
question
factor
would
incorpor
calcul
justifi
first
statist
biolog
pointsofview
sinc
main
interest
provid
proofofconcept
simpl
set
classif
algorithm
may
use
predict
amyloidosi
opt
complement
bayesian
method
decis
tree
one
could
factor
addit
effect
mutat
classifi
sequenc
decis
tree
particularli
use
classifi
unknown
one
finit
number
categori
base
result
seri
test
attribut
sampl
work
pose
seri
question
featur
associ
unknown
question
contain
node
node
child
node
possibl
answer
question
eventu
termin
leav
correspond
classif
mani
variant
decis
tree
simplest
form
yesno
path
follow
throughout
classif
process
other
probabl
distribut
class
use
order
estim
condit
probabl
item
reach
leaf
belong
class
defin
biolog
use
parkinson
diseas
manag
diseas
sever
profil
toxic
analysi
largescal
proteom
studi
microarray
data
classif
phylogenet
analysi
among
applic
depend
number
factor
consid
classifi
sampl
decis
tree
may
made
hand
construct
automat
use
learn
optim
algorithm
choos
factor
arrang
tree
optim
separ
sampl
remain
challeng
creation
decis
tree
algorithm
sinc
develop
optim
tree
creation
studi
four
split
variabl
consid
base
mutat
trend
observ
amyloidogen
nonamyloidogen
sampl
order
obtain
weight
split
variabl
mutat
matric
gener
amyloiodogen
nonamyloidogen
deriv
differ
germlin
interest
result
analysi
matric
mutat
exclus
found
expos
cdr
residu
amyloid
former
appear
implic
higher
sheetform
propens
exclus
buri
fr
residu
involv
shift
residu
lower
sheetform
propens
figur
tabl
may
suggest
mutat
stabil
sheet
structur
cdr
normal
assum
loop
structur
contribut
much
amyloidosi
destabil
sheet
structur
critic
region
ie
buri
fr
residu
unlik
base
previou
observ
hurl
et
al
instanc
perform
posit
analysi
amyloidogen
sequenc
find
mutat
occur
less
sequenc
particular
posit
mutat
mostli
found
cdr
notabl
light
chain
furthermor
steven
et
al
observ
invari
residu
light
chain
drastic
affect
structur
antibodi
upon
mutat
found
protein
surfac
make
obviou
contribut
fold
mutat
cdr
gener
vari
contribut
amyloidosi
though
easi
pinpoint
probabl
signific
final
result
consist
predict
use
method
see
supplementari
inform
addit
file
consist
may
view
valid
observ
observ
decis
tree
creat
approxim
contribut
mutat
overal
amyloidogen
sequenc
use
tree
independ
test
set
yield
predict
accuraci
tabl
close
predict
accuraci
obtain
decis
tree
test
train
set
sequenc
loo
cross
valid
perform
method
sinc
would
requir
weight
chang
mani
time
sequenc
classifi
gener
train
set
appear
better
perform
naiv
bayesian
method
one
possibl
reason
factor
taken
consider
one
approxim
effect
mutat
well
effect
particular
region
time
also
roughli
approxim
combin
effect
mutat
like
equal
respons
misfold
individu
mutat
nevertheless
impli
naiv
bayesian
method
entir
without
merit
sinc
clear
posit
combin
posit
mutat
occur
key
role
amyloidosi
also
evid
sequenc
use
naiv
bayesian
method
predict
result
also
probabl
improv
includ
addit
factor
hydrophil
size
charg
chang
split
variabl
refin
posit
base
preced
studi
ad
split
variabl
construct
decis
tree
could
perform
use
autom
optim
algorithm
caveat
method
howev
possibl
overfit
descript
random
error
instead
true
correl
phenomenon
one
key
problem
machin
learn
may
occur
degre
freedom
data
overfit
model
result
repres
popul
behavior
unlik
replic
sever
rule
thumb
avoid
overfit
includ
minimum
observ
per
predictor
variabl
larger
sampl
size
requir
case
effect
size
small
predictor
highli
correl
binari
respons
model
sampl
size
may
directli
relev
although
problem
appear
sampl
size
play
import
role
due
limit
sampl
set
size
possibl
perform
singl
holdout
valid
loo
cross
valid
whose
result
consist
howev
futur
work
involv
larger
train
set
would
possibl
includ
measur
perform
definit
test
ensur
overfit
elimin
minim
exploratori
studi
indic
naiv
bayesian
classifi
decis
tree
may
use
ye
type
predict
amyloidogen
sequenc
analysi
result
method
suggest
predict
accuraci
may
improv
optim
train
set
size
incorpor
inform
alter
brought
mutat
calcul
factor
may
consid
includ
hydrophil
charg
chang
brought
replac
residu
respect
locat
well
way
mutat
cluster
sequenc
known
structur
anoth
factor
might
consid
sequenc
immunoglobulin
fold
implic
mutat
ntermin
region
first
fold
develop
classif
techniqu
includ
possibl
creat
hybrid
naiv
bayesian
decis
tree
appear
worthwhil
method
may
eventu
adapt
predict
amyloidogen
nonimmunoglobulin
sequenc
train
set
compris
amyloidogen
nonamyloidogen
deriv
germlin
obtain
nation
center
biotechnolog
inform
ncbi
http
wwwncbinlmnihgov
holdout
test
set
compris
amyloidogen
nonamyloidogen
sequenc
chosen
account
absenc
gap
well
possibl
assign
unambigu
germlin
set
also
obtain
ncbi
sequenc
assign
closest
germlin
use
clustalw
result
align
manual
annot
kabat
number
cdrfr
definit
appli
sequenc
nonamyloidogen
deriv
set
construct
randomli
chosen
deriv
germlin
deriv
set
approxim
total
number
mutat
amyloidogen
counterpart
first
five
amino
acid
residu
omit
analysi
sinc
may
primerderiv
sequenc
amyloidogen
nonamyloidogen
antibodi
use
analysi
identifi
ncbi
access
code
well
put
germlin
deriv
supplementari
inform
addit
file
gener
naiv
bayesian
classifi
germlin
basi
amyloidogen
nonamyloidogen
deriv
briefli
probabl
p
mutat
occur
posit
x
quantifi
amyloidogen
pam
nonamyloidogen
pnam
deriv
germlin
raw
valu
pam
pnam
take
valu
avoid
use
laplac
correct
method
ad
numer
denomin
respect
complement
qam
qnam
repres
retent
residu
given
pam
pnam
respect
probabl
use
calcul
amyloidogen
nonamyloidogen
propens
test
sequenc
deriv
germlin
train
set
suppos
mutat
posit
defin
set
amyloidogen
probabl
calcul
nonamyloidogen
probabl
calcul
x
refer
posit
figur
greater
nam
sequenc
classifi
amyloidogen
otherwis
classifi
nonamyloidogen
classifi
accuraci
crosscheck
train
test
set
use
due
limit
number
sequenc
obtain
valid
preliminari
consist
loo
crossvalid
perform
amyloidogen
nonamyloidogen
deriv
onetim
holdout
test
valid
weight
decis
tree
construct
provid
quantit
estim
individu
joint
contribut
mutat
function
locat
ie
cdrfr
exposur
chang
sheet
form
propens
step
gener
tree
shown
figur
initi
separ
mutat
matric
buri
cdr
residu
buri
fr
residu
expos
cdr
residu
expos
fr
residu
gener
align
amyloidogen
nonamyloidogen
deriv
base
algorithm
describ
expos
residu
defin
residu
access
surfac
exposur
inform
gener
align
use
structur
homologu
germlin
sequenc
see
supplementari
inform
addit
file
visual
facilit
easier
analysi
postprocess
subtract
nonamyloidogen
amyloidogen
matrix
imag
result
imag
rel
intens
proport
predomin
specif
mutat
binari
matrix
contain
mutat
exclus
amyloidform
also
gener
matric
residu
arrang
accord
increas
propens
tabl
origin
residu
row
replac
residu
column
mutat
right
diagon
associ
increas
sheetform
propens
left
correspond
decreas
sheetform
propens
figur
figur
step
trend
observ
matric
figur
step
tabl
use
weight
associ
branch
tree
point
determin
path
taken
amyloid
nonamyloidform
could
gener
show
germlin
depend
led
identif
path
may
use
maxim
separ
amyloidogen
nonamyloidogen
deriv
per
germlin
tabl
figur
step
instanc
amyloidogen
deriv
maxim
separ
correspond
nonamyloidogen
deriv
give
tenfold
higher
score
mutat
follow
path
lead
leaf
tenfold
lower
score
mutat
lead
leaf
boost
decreas
path
specif
leav
indic
tabl
boldfac
ital
respect
consequ
trace
path
tree
describ
mutat
yield
score
calcul
product
weight
along
path
use
strategi
averag
amyloidogen
potenti
everi
sequenc
amseq
calcul
follow
correspond
score
individu
mutat
n
correspond
number
mutat
sequenc
sinc
amplifi
certain
path
amyloidogen
sequenc
expect
higher
amseq
valu
threshold
classifi
sequenc
amyloidogen
nonamyloidogen
defin
per
germlin
base
averag
score
amyloidogen
deriv
figur
step
crossvalid
perform
holdout
test
set
figur
step
mpcd
gpc
eap
jointli
conceptu
project
eap
obtain
manual
annot
amyloidogen
sequenc
germlin
assign
mpcd
implement
program
naiv
bayesian
analysi
decis
treebas
classif
perform
analysi
result
author
read
approv
manuscript
form
